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ABSTRACT OF THE THESIS 
 
 
 
Does Empowerment Predict Vaccine Uptake? 
 
Identifying Early Adopters of Recently-Introduced  
 
Childhood Vaccines in Malawi 
 
 
 
by 
 
 
 
Kimberly Clair 
 
Master of Science in Community Health Sciences 
 
University of California, Los Angeles, 2019 
 
Professor Randall S. Kuhn, Chair 
 
 
 
 
The Human papillomavirus (HPV) vaccine was introduced to Malawi to reduce the high rate of 
cervical cancer mortality among Malawian women. This thesis analyzed 2015-16 Malawi 
Demographic and Health Survey data collected from currently married or partnered women ages 
15-49 to identify characteristics associated with adoption of two recently-introduced childhood 
vaccines (rotavirus and pneumococcal), which served as a proxy for the HPV vaccine. 
Multivariate logistic regression was conducted to identify early adopters who had vaccinated 
their youngest child against rotavirus and pneumococcal infection. The results of my analyses 
show that women’s empowerment, assessed through participation in family decisions and 
attitudes towards violence, women’s exposure to media, and women’s employment status were 
positively associated with adoption of both the rotavirus and pneumococcal vaccines. Identifying 
 iii 
which Malawian women are less likely to vaccinate their children could inform specialized 
interventions designed to reach these sub-populations. Identifying determinants of vaccine 
adoption is an important step towards improving HPV vaccine uptake and ultimately reducing 
cervical cancer mortality in Malawi. 
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 1 
INTRODUCTION 
 
 Malawi has the highest incidence of cervical cancer in the world (Campbell et al. 2016). 
Each year, approximately 3,684 Malawian women are diagnosed with the disease, 80% of whom 
will die prematurely due to cervical cancer (Maseko et al., 2015:2; Fort et al., 2011:125). 
Cervical cancer can be prevented by protecting sexually active women from Human 
papillomavirus (HPV), including through vaccination. Two brands of the vaccine, Gardasil® 
and Cervarix®, have proven 95% efficacious in preventing infection from the most high-risk 
type of HPV: strains 16 and 18 (Cutts et al., 2007; Perlman et al., 2014). From 2013-2016, a pilot 
demonstration that took place in two districts in Malawi successfully vaccinated 26,766 in-
school girls aged 13 following informed written consent obtained from caregivers, resulting in 
over 80% coverage (Mysyamboza et al., 2017). Following this small-scale pilot demonstration, 
the Malawi Ministry of Health launched a national HPV vaccine campaign in January 2019 that 
aims to vaccinate a cohort of 240,000 girls aged 9 across the country before expanding to include 
1.5 million girls ages 9-14 (Magombo-Mana, 2019). Vaccinating girls before they become 
sexually active may help reduce the spread of HPV, which can in turn reduce cervical cancer 
mortality in Malawi.  
 Although the HPV vaccine is provided at no cost through this government rollout, it 
remains unclear whether Malawian families will take advantage of the opportunity to vaccinate 
their daughters. Previous studies in sub-Saharan Africa have shown that limited knowledge about 
cervical cancer, as well as concerns about the vaccine’s side effects may discourage uptake of the 
HPV vaccine (Vermandere et al., 2014). Malawian families may also have concerns about the 
fact that the HPV vaccine targets young girls, aims to prevent a sexually transmitted disease, and 
requires more than one dose in order to be effective. Similar concerns have emerged in other 
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settings, including the United States (Sipp et al., 2018). However, because the HPV vaccine is 
new to Malawi, little is known about whether such attitudes, behaviors, or characteristics among 
Malawian families will be associated with uptake of the HPV vaccine. This thesis aims to 
identify whether Malawian women’s health service utilization and empowerment are positively 
associated with uptake of other recently-introduced vaccines, which will serve as a proposed 
proxy for their willingness to uptake the HPV vaccine. 
Preventing Cervical Cancer in Malawi 
Sub-Saharan Africa has the highest cervical cancer rates in the world, and rates are 
projected to increase within the next twenty years (De Vuyst et al, 2013; Denny, 2013). To 
prevent new cases from occurring, the World Health Organization (WHO) published a 
guidebook on cervical cancer control with recommended approaches for governments and health 
agencies. Vaccinating girls ages 9-13 with at least two doses of the HPV vaccine is 
recommended as a primary prevention strategy (WHO, 2014). For secondary prevention, women 
aged 30 and older are encouraged to receive cervical cancer screenings, which can detect the 
presence of precancerous cells. Countries with available screening have seen a reduction in 
cervical cancer incidence rates by as much as 80% (American Cancer Society, 2012: 26). At the 
tertiary level of prevention, community mobilization, health education, and counselling are 
recommended to increase awareness about cervical cancer among community members 
(including parents, educators, health professionals, and leaders), which may in turn increase rates 
of cervical cancer screening and vaccination. Since almost all cases of cervical cancer are 
attributable to HPV infection (Sankaranarayanan, Qiao & Keita, 2015; De Martel at al., 2017), 
promoting awareness of cervical cancer, HPV, and safe sex behaviors are recommended to 
prevent the spread of HPV. Finally, the guide recommends addressing poverty, gender 
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inequality, and barriers to accessing health facilities, which also impact women’s ability to 
effectively prevent and/or treat cervical cancer.  
Cervical Cancer Screening 
In the last decade, Malawi has seen an increase in the number of cervical cancer deaths—
a pattern also observed in other developing countries (Maseko et al., 2015:2). Since 2004, the 
Malawi Ministry of Health has implemented a national Cervical Cancer Control Programme 
(CECAP), which focuses primarily on promoting cervical cancer screenings among eligible 
women (United Nations Population Fund [UNPFA], 2017). In low or middle-income countries 
(LMICs), the World Health Organization recommends a “screen-and-treat” or a “screen, 
diagnose, and treat” approach (WHO, 2019). In Malawi, visual inspection with acetic acid (VIA) 
is used to offer detection of precancerous cells on the cervix, followed immediately with 
cryotherapy, or loop electrosurgical excision for removal of these cells (Fort et al., 2011: 125-26; 
Campbell et al., 2016: 908). However, successfully implementing cervical cancer screening 
programs has been a challenge due to a lack of available trained health personnel, medical 
supplies, and access to facilities (Maseko et al., 2015: 2). For treatment using cryotherapy, 
inconsistent gas supplies, malfunctioning machines, and the costs of running and transporting 
equipment have also interfered with delivery of screening services (Campbell et al., 2016). An 
analysis of data collected by the Malawi Cervical Cancer Control Programme (2011-2015) found 
that only 43.3% of 2,311 women who were referred for treatment following VIA actually 
received treatment, primarily as a result of malfunctioning or missing cryotherapy machines 
(Msyamboza et al., 2016: 1).  
Additional barriers to cervical cancer screening uptake among Malawian women include 
difficulty accessing transportation to visit and/or return to healthcare facilities; failure to obtain a 
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referral for screening; low public awareness about the relationship between screening and 
treatment procedures; and failure to obtain permission from one’s husband to return for follow-
up care (Fort et al., 2011; Kunckler et al., 2017). Although Malawi saw an increase in the 
number of women who had ever been screened for cervical cancer (from 14% in 2012 to 27.3% 
in 2015), the coverage rate continues to fall below the targeted rate of 80% (UNPFA, 2017: 25).  
Vaccination  
As a primary prevention strategy, vaccinating Malawian girls before they become 
sexually active can eliminate many of the aforementioned challenges. National immunization 
programs that include vaccinations against HPV 16 and 18 infections have been introduced in 
more than 60 countries (Sankaranarayanan, Qiao & Keita, 2015). However, the high cost of the 
vaccine, misinformation about the side effects and effectiveness of the vaccine, and problems 
with service delivery have hampered efforts to implement such programs in low resource settings 
(Sankaranarayanan, Qiao & Keita, 2015: 203). The vaccine’s multiple dose requirement can also 
interfere with successful coverage. In LMICs, it is recommended that girls receive two doses of 
HPV over a 2-year period, with an interval of at least 6 months and no more than 12 months 
between each dose (Sankaranarayanan, Qiao & Keita, 2015). Achieving successful coverage of 
the HPV vaccine can be considerably more challenging than for one-time, one-shot vaccinations, 
such as the measles-rubella or yellow fever vaccines (World Health Organization [WHO], 2016: 
10). However, some studies have suggested that receiving only one dose of bivalent HPV 
vaccine may sustain antibody responses for up to four years following vaccination (Kreimer et 
al., 2015; Sankaranarayanan et al., 2018).  
In Malawi, the Global Alliance for Vaccines and Immunization (GAVI) has helped 
reduce the cost of the HPV vaccine and supported the 2013-16 pilot demonstration project, 
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which was carried out in Rumpha (Northern Malawi) and Zomba (Southern Malawi) (UNFPA, 
2017). Although this pilot project achieved a coverage rate of 90% for both districts, coverage 
was substantially lower for girls who received vaccinations from a health facility compared to 
girls who received school-based delivery (Msyamboza, 2017; UNFPA, 2017). In addition, 
school-based delivery resulted in vaccination of girls outside of the recommended age range 
(both younger than 9 and older than 14), resulting in an inappropriate use of limited resources 
(vaccines) and may have interfered with vaccine effectiveness, since a 3-dose schedule is 
recommended for girls ages 14 and older (Msyamboza, 2017: 5).  
Uptake of the HPV vaccine is influenced by multiple factors, including individual 
knowledge and awareness of the vaccine, attitudes towards the vaccine, and perceived benefits of 
and barriers to adopting the vaccine. HPV awareness has been defined as having ever heard of 
HPV or “a shot to prevent cervical cancer,” while HPV knowledge includes an accurate 
understanding of the relationship between HPV and cervical cancer, modes of HPV transmission, 
and HPV treatment methods (Allen, 2010; Francis et al, 2011; Morales-Campos & Vanderpool, 
2017). A systematic review of HPV acceptability and related factors among African adults 
reported considerable variations in HPV-related knowledge and consistently low levels of HPV 
awareness (Cunningham, Davison & Aronson, 2014). Similarly, a systematic review of findings 
from 13 sub-Saharan African countries (excluding Malawi) found low levels of knowledge and 
awareness of cervical cancer, HPV, or the HPV vaccine (Perlman et al., 2014). Low 
knowledge/awareness of HPV has been identified in Uganda (Katahoire et al., 2008), Tanzania 
(Remes et al., 2012), Botswana (DiAngi et al., 2011), Mali (De Groot et al., 2017), and Nigeria 
(Bisi-Onyemaechi et al. 2018). 
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The decision to vaccinate one’s daughter is also influenced by perceived severity of 
cervical cancer, perceived susceptibility to cervical cancer, the belief that vaccination reduces the 
risk of cervical cancer and/or provides other health benefits, and a perceived absence of barriers 
to taking preventative action (Vermandere et al., 2016). Perceived benefits of HPV vaccine 
uptake include protection against future HPV infection and/or protection against cervical cancer 
and promotion of girls’ reproductive health (Francis et al., 2011). The perceived barriers to HPV 
vaccine uptake among families in sub-Saharan Africa include concerns about the cost of the 
vaccine, difficulties finding or accessing health facilities, perceived risks associated with 
receiving the vaccine, and concerns about the vaccine’s safety and/or effectiveness (PATH, 
2009; Becker-Dreps, 2010; Coleman, 2011; DiAngi, 2011; Francis et al., 2011; Bisi-Onyemaechi 
et al. 2018). These perceived barriers intersect with self-efficacy, which, in the context of HPV 
vaccine uptake, refers to a family’s perceived ability to make decisions about their daughter’s 
health and to act on these decisions. In sub-Saharan Africa, decisions about child health, 
including vaccinations, are typically considered a mother’s responsibility (Ports, 2013). 
However, women’s perceived ability to act on these types of decisions is associated with a 
number of factors related to women’s “autonomy” or “empowerment”—such as needing 
approval from her husband/partner. A study on HPV vaccine acceptability in Kenya found that 
perceived disapproval of the HPV vaccine from husbands/partners lowered women’s 
acceptability of the HPV vaccine for their daughters (Vermandere et al., 2014). 
Despite low levels of HPV-related knowledge and awareness, research has consistently 
shown that HPV vaccine acceptability—willingness and intention to vaccinate—is high among 
parents in sub-Saharan Africa and is influenced by the degree to which trusted community 
members support or oppose HPV vaccination (Coleman, 2011; Francis et al., 2011; Cunningham, 
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Davison & Aronson, 2014). For example, a systematic review of HPV vaccine knowledge, 
awareness, acceptability, and willingness to vaccinate found high levels of acceptability in 12 of 
the 13 sub-Saharan African countries evaluated, with some countries achieving HPV vaccine 
coverage rates above 90% (Perlman et al., 2014). HPV vaccine acceptability among parents has 
been associated with having a recommendation from a healthcare provider (Francis et al., 2010; 
Makwe et al., 2012; Ports et al., 2013) or from the government (Remes et al., 2012). Favorable 
attitudes of community members towards the HPV vaccine was also associated with HPV 
vaccine acceptance in Uganda, Nigeria, and Ghana (Iliyasu et al., 2010; Katahoire et al., 2008; 
Coleman et al., 2011). Additionally, the views of school officials, health workers, and political 
leaders have been shown to influence parents’ HPV vaccination decisions (PATH, 2009: 18). 
Social norms and attitudes concerning girls’ sexuality may act as additional barriers to 
HPV vaccine uptake. Fears that the HPV vaccine would encourage sexual promiscuity among 
girls has influenced HPV vaccine acceptability among parents in Uganda and Nigeria 
(Ezeanochie & Olagbuki, 2014: 154) and among male teachers in Tanzania (Remes et al., 2012). 
In the HPV vaccine pilot demonstration project that took place in Rumpha and Zombi (Malawi), 
researchers found that the belief that the HPV vaccine was “not good for girls” contributed to 
vaccination refusals (Msyamboza et al., 2017:3). Interpersonal relationships, media, policies, and 
institutional/health-systems factors also influence individual attitudes towards and decisions 
about the HPV vaccine (Allen, 2010: 4034). In addition, prior experience with immunization 
may impact acceptability. Vaccine acceptability among parents in Malawi was linked to having 
previously vaccinated one’s child and having a positive experience (Ports et al., 2013) while in 
Uganda, HPV vaccine acceptability was correlated with perceived effectiveness of previously 
received vaccines (Katahoire, 2008). 
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THEORETICAL FRAMEWORK 
This thesis is grounded in the theory of “diffusion of innovation” (Rogers, 1983), which is 
concerned with the processes associated with adoption or rejection of a new idea, practice, or 
object (Rogers, 1983: 11). Diffusion is defined as “the process by which an innovation is 
communicated through certain channels over time among the members of a social system” 
(Rogers, 1983: 6). For Rogers, diffusion differs from other types of communication in that it 
involves a new idea, practice or object, and, as a result, brings uncertainty about the innovation’s 
anticipated consequences (Rogers, 1983: 7). The process of deciding whether to adopt or reject 
the innovation involves a complex interaction of individual, interpersonal, and 
societal/environmental factors. Rogers identifies five steps in the innovation-decision process at 
the individual-level, including 1) knowledge of the innovation’s existence and functions, 2) 
persuasion, or, the formation of a favorable or unfavorable attitude toward the innovation, 3) 
decision, or activities that lead to the adoption or rejection of the innovation, 4) implementation, 
or utilization the innovation to use, 5) confirmation (and potential reversal of) one’s previous 
decisions regarding the innovation (Rogers, 1983: 20-21).  
 Rogers examines the relative rate of adoption, an individual’s social status, and the and 
communication systems available in a particular social system to develop “adopter categories,” 
which help describe an individual’s attitudes towards “innovativeness,” or, the degree to which 
an individual is early in adopting innovations relative to other members of the social system 
(Rogers, 1983: 22). At the earliest end of the spectrum are “innovators,” who have a high degree 
of exposure to new information (either through media or social/informal networks), are active 
information-seekers, and have a higher tolerance for uncertainty than individuals at other ends of 
the adoption spectrum (Rogers, 1983: 22). Others have identified innovators as risk-takers who 
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are typically more educated, cosmopolitan, and have a higher degree of appreciation for 
technology than their peers (Haider & Kreps, 2004; Kaminski, 2011). Additional adopter 
categories include early adopters, early majority, late majority, laggards, and non-adopters. 
Laggards and non-adopters, who are skeptical or suspicious of innovations, are theorized to have 
lower education and weaker peer-network connections than adopters (Rogers, 1983: 292; Haider 
& Kreps, 2004).  
 Rogers has identified key differences between early adopters and later adopters with 
respect to socio-economic status, personality traits, and communication behaviors (Rogers, 1983: 
279). Early adopters tend to have more years of education, higher levels of literacy, higher socio-
economic status, and greater degree of upward social mobility compared to late adopters 
(Rogers, 1983: 279). Earlier adopters may also have greater tendency towards empathy, a greater 
ability to deal with abstractions, a positive attitude towards change, and higher achievement 
motivation (Rogers, 1983: 279; Haider & Kreps, 2004). In contrast, late adopters are 
characterized by lower levels of education, lower social status, and lower utilization of mass 
media channels compared to early adopters. Late adopters may be forced to adopt an innovation 
due to social or economic pressures and, as a result, are more likely to discontinue utilization of 
an innovation (Rogers, 1983: 188). With respect to communication, Rogers suggests that early 
adopters find mass media channels more important than interpersonal communication while for 
later adopters, the immediacy of interpersonal networks has a greater influence over the decision 
to adopt or reject an innovation (Rogers, 1983: 201). Early adopters are also more likely to 
engage in active information-seeking, have greater knowledge of innovations, and belong to 
interconnected social systems compared to late adopters (Rogers, 1983: 270). 
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 Additional factors that influence the innovation-decision process include the relative 
advantage of an innovation over a previous idea, practice, or product; the compatibility of the 
innovation with an individual’s values, beliefs, and past experiences; the degree of complexity, 
or perceived difficulty in understanding or using the innovation; “trialability”—the degree to 
which an innovation may be experimented with on a limited basis; and observability, or, the 
degree to which the results of an innovation are visible to others (Rogers, 1983: 15). These 
factors are considered the strongest predictors of an individual’s intention to adopt an innovation 
(D’Souza et al., 2013).  
 Theories of diffusion of innovation may be modified by the particular characteristics of 
an innovation and/or the environment in which an innovation is introduced. For example, Rogers 
has suggested that innovation decision-making and adoption behaviors may differ for 
“preventive innovations,” or innovations that aim to avoid the potential occurrence of an 
unwanted future event, such as a natural disaster (Rogers, 1983: 171). Because the unwanted 
event may occur regardless of whether the innovation is adopted, an individual’s uncertainty is 
likely to be higher and the rate of adoption is likely to be slower (Rogers, 1983: 171). The reward 
of adopting a preventive innovation may be delayed, intangible, and have a lower relative 
advantage than non-preventive innovations (Rogers, 2002: 991). Increasing the rate and 
frequency of adoption for a preventive innovation requires a different set of strategies (Rogers, 
2002: 992).  
 The role of “opinion leaders” may be enhanced in instances of preventive diffusion. For 
Rogers, an opinion leader is an innovator who frequently influences other individuals’ attitudes 
and/or behavior such that “the success or failure of diffusion programs rests in part on the role of 
opinion leaders” (Rogers, 1983: 27). First, opinion leaders may be able to lower levels of 
 11 
uncertainty or perceived risk, which are typically higher for preventive innovations or 
innovations about which little is known (Rogers, 1983: 168). Second, opinion leaders can add 
nuance and personalized information to the “one-size-fits-all” approach that often characterizes 
mass media campaigns, making information about an innovation more relevant to members of 
the opinion leader’s peer or community group (Rosen & Goodson, 2014: 44). According to 
Rogers, opinion leaders are able to appeal to the affective dimension of the innovation-decision 
process by helping individuals form an attitude or feeling toward a particular innovation (Rogers, 
1983: 170). Third, by occupying an intermediary role within a large social network, opinion 
leaders may facilitate communication across diverse social groups. A study of U.S.-based school 
nurses found that nurses were well-positioned to disseminate information about the HPV vaccine 
to students, in part because of their ability to act as liaisons for families, school staff, healthcare 
professionals and communities (Rosen & Goodson, 2014: 44). Fourth, opinion leaders can help 
ensure maintenance of an adopted behavior. In Malawi, women who had continual contact with 
health workers and were able to discuss the benefits of the intervention with these opinion 
leaders both adopted and maintained a chlorine water treatment intervention (Wood et al., 2012). 
 Criticisms of diffusion research point to its reliance on generalizations, its underlying 
“pro-innovation” bias, its potential for recall bias, its emphasis on individual-level behaviors, and 
issues with equality (Rogers, 1983: 91; Haider & Kreps, 2004: 7). The “pro-innovation” bias 
refers to the assumption that innovations are inherently “good,” associated with progress, 
improvement, or other positive or socially desirable qualities. This assumption not only 
overlooks the possibility of “bad” or harmful innovations; it also tends to reduce the complex 
ways in which individuals interact with innovations into a dichotomy of adoption/rejection 
(Haider & Kreps, 2004: 7). Diffusion research has also been criticized for its reliance on 
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individual recall to identify the timing of innovation adoption, which increases the likelihood of 
measurement bias (Rogers, 1983: 113). In addition, diffusion research has been criticized for 
examining individual decision-making processes and behaviors without sufficient attention to the 
social and political systems in which individuals operate. Marketing research has suggested 
attention to three domains: individual users, the community of users, and the innovating industry 
or market (MacVaugh & Schiavone, 2010: 206). Others have suggested that diffusion research 
pays insufficient attention to the socio-political consequences of innovation-stratification, in 
which social divisions based on wealth and education may be reified or magnified (Haider & 
Kreps, 2004: 7).  
Effects of Empowerment on Innovation Adoption  
While certain individual characteristics may prove useful for predicting uptake of a health 
innovation, these factors cannot be analyzed separately from the broader socio-political 
environment, which determines individuals’ exposure to information, ability to access 
innovations, and ability to act on the decision to take up an innovation. For this reason, studies of 
women’s decision-making processes and behaviors must attend to issues of gender inequality. 
Gender inequality has been defined as systematic discrimination against women and girls that 
creates disadvantages in economic status, educational attainment, health outcomes, and other 
aspects of human development and significantly constrains women’s and girls’ capabilities and 
opportunities (UNDP, 2019). Efforts to identify and evaluate gender equality in relation to 
women’s health service uptake behaviors have relied on concepts such as “empowerment,” 
“autonomy,” or “agency” (Malhotra, Schuler & Boender, 2002). This thesis uses the term 
“empowerment” to refer to a range of factors influencing women’s ability to make and act on 
informed decisions.  
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 Empowerment remains a challenging concept to define, quantify, and measure. Social 
science researchers have defined empowerment as an ability to make choices, a function of 
women’s economic decision-making power, and a measure of “achievements,” including 
educational attainment, literacy, employment, and exposure to mass media (Kabeer 1999; 
Anderson & Eswaran, 2009). Empowerment has also been linked to women’s social inclusion, as 
marked by their participation in civil society and kinship networks, and their ability to alter 
power dynamics or remove constraints that adversely impact their health and well-being 
(Malhotra, Schuler & Boender, 2002). Self-determination, self-confidence, and self-efficacy—
the perceived ability to act on one’s knowledge and attitudes—have also variously factored into 
measures of empowerment, suggesting that researchers conceptualize “empowerment” as a 
dynamic process rather than a fixed position (Asaolu et al., 2018).   
 To measure women’s empowerment, studies typically rely on composite measures that 
address economic, socio-cultural, familial/interpersonal, legal, political, and psychological 
dimensions of women’s lives (Malhotra, Schuler & Boender, 2002). For example, Kabeer 
suggests viewing empowerment as a combination of resources (a reflection of a woman’s pre-
existing socio-economic standing), agency (a woman’s ability to pursue her personal life goals), 
and achievements (Kabeer, 1999: 437-438). For Kabeer, agency refers not only to the authorial 
decision-making power associated with community leaders and household heads but also an 
internalized “sense” of power—that is, the ability to “define one’s goals and act upon them” 
(Kabeer, 1999: 438). The 2015-16 Malawi Demographic and Health Survey identifies women’s 
employment and control over earnings, ownership of property, participation in major household 
decisions, and attitudes towards wife beating as indicators of women’s empowerment (NSO, 
2017: 251). To create consistency across analyses of empowerment using DHS data from Africa, 
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the Survey-Based Women’s Empowerment (SWPER) Index was developed and consists of three 
domains: women’s attitudes towards violence, social independence, and decision-making power 
(Ewerling et al., 2017). However, subsequent factor analyses have suggested that only attitudes 
toward violence, access to healthcare, and labor force participation are consistently relevant 
indicators of empowerment in African countries (Asaolu et al., 2018). The Malawi DHS 
measures women’s decision-making power in relation to their participation in four different 
types of decisions: the respondent’s healthcare, making large household purchases, visiting 
family or relatives, and spending money the husband/partner earned (NSO, 2017). Quantitative 
studies on Malawian women’s empowerment have operationalized these variables in different 
ways, such as selecting only those variables that identify women’s participation in economic 
decisions (Chol et al., 2019) or integrating these variables into a larger empowerment index 
(Palamuleni & Adebowale, 2014).  
 Despite significant variation in definitions of empowerment and resulting measurement 
processes, empowerment—as a reflection of the economic, social, and psychosocial constraints 
that impact women’s decision-making around, and potential uptake of, an innovation—remains a 
significant component in women’s adoption of new health technologies. In sub-Saharan Africa, 
empowerment has been shown to influence women’s decision-making processes and uptake 
behaviors for maternal and child health services and childhood vaccinations. In Botswana, 
respondents who thought they would be involved in the decision to vaccinate their daughters 
against HPV were more than twice as likely to express HPV vaccine acceptability than those 
who thought they would not be involved in the decision-making process (DiAngi et al., 2011). 
Although women are often considered to be responsible for child’s health, fathers with more 
authority in the home may have the final say on child immunization (PATH, 2009: 18). Analyses 
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of data from 31 sub-Saharan African countries found that women’s autonomy—defined as 
women’s attitudes towards sexual and domestic violence and women’s participation in financial 
and household decisions—was associated with utilization of maternal healthcare services (Chol 
et al., 2019).  
 In Malawi, gender inequality persists within women’s marital and sexual relationships, 
educational attainment, economic activity, and political participation. Malawian women face 
high rates of gender-based violence, with 34% of women having experienced physical violence 
since age 15 (NSO, 2017). Malawian women also have lower literacy, wage equality, and 
political participation compared to men (United States Agency for International Development 
[USAID], 2018). Among adult Malawian women, only 16.7% have at least a secondary 
education compared to 25.4% of adult Malawian men (UNDP, 2018). In the United Nations 
Development Programme 2017 Gender Inequality Index, which measures women’s reproductive 
health, education, political participation, and labor market participation, Malawi ranked 148 out 
of 160 countries (UNDP, 2018). Nevertheless, these indicators may not fully capture women’s 
subjective experiences of negotiating unequal power relationships within their daily lives 
(Masset, 2015). Examining empowerment through quantitative measures alone is likely to 
produce an incomplete picture of Malawian women’s relationships to power. 
JUSTIFICATION OF STUDY VARIABLES 
Although there is no known published information on predictors of HPV vaccine uptake among 
Malawian families, diffusion of innovation theory suggests that the adoption of this health 
innovation may be associated with certain socio-demographic characteristics (education, wealth, 
and employment), greater access to information, greater access to and familiarity with related 
health technologies, and indicators of women’s empowerment. To identify factors associated 
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with uptake of the HPV vaccine, a new health technology, my analysis of DHS data incorporates 
variables associated with utilization of other new health technologies and services, women’s 
empowerment, and women’s socio-demographic characteristics. 
Vaccine Adoption 
Because the HPV vaccine is new to most Malawians, studies examining uptake of other recently-
introduced childhood vaccines—such as the pneumococcal conjugate (PCV13) and monovalent 
human rotavirus (RV1) vaccines—may be a unique source of insight for estimating factors that 
might be linked to HPV vaccine uptake. PCV13 and RV1 are the most recent introductions to 
Malawi’s national immunization program (November 2011 and October 2012, respectively) 
(NSO, 2017: 143). Like the HPV vaccine, both RV1 and PCV13 require multiple doses. A recent 
analysis of 2015-16 MDHS data used uptake of RV1 and PCV13 as an outcome variable to 
identify socio-demographic characteristics of Malawian families associated with full vaccination. 
In this study, “uptake” was defined as children ages 12-35 months who, prior to turning 1 year 
old, had received all three doses of PCV13 or the full two doses of RV1 (Ntenda et al., 2018: 3). 
The study found that, compared to children from the Southern region, the odds of PCV13 uptake 
were higher for children from the Northern region and slightly lower for children from the 
Central region while differences observed in RV1 uptake were not statistically significant 
(Ntenda et al., 2018: 7-9). Women who did not attend a baby postnatal care check two months 
after birth and women with no education were also significantly less likely to have vaccinated 
their child with either RV1 or PCV13 (Ntenda et al., 2018). In addition, women with low levels 
of media exposure were significantly less likely to achieve uptake of PCV13 compared to 
women with high media exposure in the unadjusted regression analysis (Ntenda et al., 2018). 
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 Some research has explored determinants of basic childhood vaccination in Malawi (one 
dose of the tuberculosis vaccine, three doses of the polio vaccine, one dose of the measles 
vaccine, and three doses of the vaccine against diphtheria, pertussis, and tetanus) (NSO, 2017: 
142). Young children (12-23 months) from rural areas were more likely to have received all 
basic vaccinations than children in urban areas, and children were more likely to have received 
vaccinations if their mother had a secondary education or higher compared to no education 
(NSO, 2017: 143). However, in Malawi, the majority of these vaccines have been available to 
families since 1979 through the Expanded Programme on Immunization (EPI) (Munthali, 2007). 
For this reason, RV1 and PCV2 are more appropriate substitutes for the HPV vaccine. 
Health Service Utilization 
According to diffusion of innovation theory, a major barrier to adoption is an individual’s 
uncertainty about an innovation, which may be marked by a lack of knowledge of or experience 
with products or services related to a particular innovation. For Rogers, compatibility, or “the 
degree to which an innovation is perceived as being consistent with the existing values, past 
experiences, and needs of potential adopters,” significantly influences decision-making processes 
around innovation adoption as well as the rate of adoption (Rogers, 1983: 15). With respect to 
health innovations, the compatibility aspect of innovation adoption suggests that individuals who 
have prior experience accessing health services and utilizing available health technologies are 
more likely to be “early adopters” of a newly introduced vaccine than those who are less familiar 
with, and more uncertain about, related health services. This logic informed my development of 
a health service utilization index, which aimed to distinguish individuals with prior experience 
utilizing and accessing maternal, newborn and child health (MNCH) services from those with 
lower levels of MNCH service access and uptake.  
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 Within quantitative analyses of DHS data, studies of MNCH service utilization have 
examined uptake of antenatal care, postnatal care, delivery of one’s child at a hospital or clinic 
that offers basic essential obstetric care services (“facility delivery”), and having the assistance 
of a skilled birth attendant or qualified doctor during delivery (“skilled delivery”) as indicators of 
adequate use of MNCH services (Fotso et al., 2009). To improve safe delivery among women in 
LMICs, the World Health Organization recommends at least four ANC visits occurring between 
8 and 12 weeks of gestation, between 24 and 26 weeks, at 32 weeks, and between 36 and 
38 weeks—commonly referred to as the Focused ANC model (WHO, 2016: 86). However, 
uptake of ANC care remains low across sub-Saharan Africa, particularly among poor and rural 
households (Kuuire et al., 2017). An analysis of Malawi DHS data found that women were less 
likely to receive the recommended four ANC visits in 2013 compared to 2000 (Kuuire et al., 
2017). Use of informal obstetric services, such as an unqualified birth attendant, and delivering 
outside of a health facility have been associated with increased risk of maternal morbidity and 
mortality (Essendi et al., 2011; Anyait et al., 2012). In contrast, women who utilize ANC 
services are more likely to be exposed to information on optimal breastfeeding and newborn care 
practices, which can drastically improve child health (Moran et al., 2009; Kimani-Murage et al., 
2016). 
 This index also included an assessment of women’s ability to access health services. In 
the Malawi DHS survey, women were asked whether accessing medical treatment would be 
difficult based on their knowledge of where to go, reluctance to go alone, distance to a facility, 
and need for permission and/or money for treatment (NSO, 2017). In Malawi, difficulty 
accessing transportation and obtaining permission from one’s husband/partner have been 
identified as barriers to uptake of cervical cancer services (Fort et al., 2011; Kunckler et al., 
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2017), while male control over household decisions and resources has also been shown to reduce 
women’s uptake of obstetric services in Ghana (Story et al., 2016).  
 Finally, this index included women’s adoption of modern contraceptives as an indicator 
of familiarity and prior experience with a relatively new health technology. In 1992, the modern 
contraceptive prevalence rate among married Malawian women of reproductive age was only 
7.4% (NSO, 2017: 93). With the development of a national family planning policy in the late 
1990s, which expanded family planning services, Malawi has seen a steady increase in modern 
contraceptive use among currently married women. In 2015-16, 59% of currently married 
women ages 15-49 were found to use some form of contraception, with almost all of them using 
modern contraception1 (NSO, 2017: 94).  
 Quantitative analyses of modern contraceptive use in Malawi have identified significant 
associations with many of the characteristics Rogers identifies among “early adopters,” including 
higher education and wealth and greater exposure to media. An analysis of 2010 Malawi DHS 
data found that women who belong to the richest wealth quintile were more likely to currently 
use or have ever used modern contraception compared to Malawian women in the lowest wealth 
quintile (Adebowale et al., 2014). In an analysis of 2015-16 MDHS data, women who were older 
than 19, women from the Southern or Central regions, women were who currently or formerly 
married, women with primary or secondary education, women who were currently employed, 
and women who had visited a health facility in the last 12 months had significantly higher odds 
of modern contraceptive uptake than their counterparts (Mandiwa et al., 2018). Among teen 
mothers in Malawi, utilization of other health services, including antenatal care, and exposure to 
                                               
1 The Malawi DHS report defines “modern contraceptives” as injectables, intrauterine devices (IUDs), contraceptive 
pills, implants, male/female condoms, male/female sterilization, the standard days method, lactational amenorrhea, 
or emergency contraception (NSO, 2017: 94). However, most studies that analyze MDHS data adopt a stricter 
definition. 
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media were found to predict modern contraceptive use (Machira & Palamuleni, 2017). Other 
predictors of modern contraceptive use in Malawi include respondent’s and partners’ approval of 
family planning and having a family planning discussion with one’s partner (Palamuleni, 2013). 
Empowerment Indicators 
 As noted above, empowerment is an important component of women’s decision-making 
processes around, and adoption of, innovative health technologies. Despite having adequate 
information about and favorable attitudes towards a health innovation, women who need to 
consult with or seek permission from their husbands/partners may be unable to act on their 
willingness to adopt a new health technology. A systematic review of studies in low-resource 
countries found that quantitative measures of empowerment were positively associated with 
women’s uptake of maternal and child health services, including antenatal care, skilled 
attendance at birth, contraceptive use, and full vaccination of children, with economic 
empowerment, health empowerment, and social empowerment among the most commonly used 
indicators (Pratley, 2016). Similarly, a systematic review of studies on child immunization in 
South Asia and Africa found that women’s agency, which commonly included decision-making 
ability and financial control, was positively associated with complete vaccination of children 
(Thorpe et al., 2016).  
 Research on empowerment and reproductive health service utilization suggests that there 
may be an interaction effect between women’s use of contraceptives and decision-making power 
within the family. For example, despite high knowledge and awareness of modern contraceptives 
reported among reproductive-aged women in Ghana, uptake was low and was positively 
associated with receiving consent and support from husbands/partners (Beson, Appiah & 
Adomah-Afari, 2018). In Ethiopia, women who had communicated with their husbands about 
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family planning were 2.58 times more likely to use modern contraceptives compared to women 
who had not (Debebe, Andualem & Biadgo, 2017). Malawian women who use Long Acting and 
Permanent Contraceptives Methods (LAPCM) were found to have higher empowerment 
scores—an index that included women’s educational attainment, work status, ability to refuse to 
have sex with partner(s), and perception of ability to ask their partner to use condom (Palamuleni 
& Adebowale, 2014: 64). Women were allocated points for each domain of empowerment; these 
points were then summed and categorized into four groupings: not empowered, poorly 
empowered, fairly empowered, and highly empowered (Palamuleni & Adebowale, 2014: 66). 
Similarly, a multilevel analysis of 32 sub-Saharan countries found that women’s empowerment 
was positively associated with whether women had ever used contraception (Yaya et al., 2018). 
In this study, empowerment was defined by current employment status, attitudes towards 
violence against women, ability to participate in decisions regarding household expenses and the 
respondents’ healthcare, and a knowledge index consisting of educational level and exposure to 
media.  
 Women’s perceptions towards violence against women have also been operationalized as 
an indicator of empowerment (Pratley, 2016). In an analysis of 2015-16 DHS data in Malawi, 
attitudes that accept violence against women were more common among both women and men in 
rural areas compared to urban areas and among women with lower levels of education (NSO, 
2017: 257). An analysis of Eritrean DHS data found that the belief that violence against women 
was justified was positively associated with having never used modern contraceptives 
(Woldemicael, 2008). 
 This study examines women’s empowerment through an index of decision-making power 
and women’s attitudes towards violence. Although women’s exposure to media, women’s 
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employment status, and women’s educational levels have been incorporated into composite 
measures of empowerment, this study examined media exposure as one of several socio-
demographic characteristics (i.e., access to information) hypothesized to predict innovation 
adoption according to diffusion of innovation theory. Employment status, education, wealth, and 
husband/partner’s education were also included within women’s socio-demographic 
characteristics to test whether these particular traits, hypothesized as characteristics of “early 
adopters,” were associated with uptake of recently-introduced childhood vaccines. Table 1 
identifies variables used from the Malawi DHS to evaluate women’s health service utilization, 
empowerment, and socio-demographic characteristics.  
 
Table 1. Justification for selection of study variables 
Theoretical Construct Dimensions MDHS Variables 
"Compatibility" Prior experience with an innovation Health service utilization index 
 
Favorable attitudes towards an 
innovation Modern contraceptive use 
  Antenatal care visits (> 3) 
  Postnatal care check 
  Facility delivery 
  No problem accessing medical care 
   
"Empowerment" 
Ability to make decisions and affect 
outcomes Decision-making power 
 
Ability to control resources and life 
options Respondent's healthcare 
 Self-efficacy Large household purchases 
  Visiting friends / relatives 
  Attitudes towards violence 
   
"Early adopter" 
characteristics Participation in social/economic life Maternal education 
  Husband/partner's education 
  Employment status 
  Wealth 
  Access to information Media exposure 
* Index constructed from existing DHS variables  
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RESEARCH QUESTIONS 
This thesis aims to address the following hypotheses using data collected from the 2015-16 
Malawi Demographic and Health Survey: 
Hypothesis 1: Compared to women with low levels of health service utilization, women 
with high levels of health service utilization will have increased likelihood of 
RV1/PCV13 adoption. 
Hypothesis 2: Compared to women who participate in 0 family decisions, women who 
participate in 3 family decisions will have increased likelihood of RV1/PCV13 adoption.  
Hypothesis 3: Compared to women who accept violence against women, women who do 
not accept violence against women will have increased likelihood of RV1/PCV13 
adoption.  
METHODS 
To examine whether Malawian women’s health service utilization and empowerment 
indicators were associated with uptake of the RV1 and PCV13 vaccines, I performed a secondary 
analysis of data collected from the 2015-16 Malawi Demographic and Health Survey (MDHS, 
2017). This dataset includes responses from 24,562 currently married or partnered women ages 
15-49 who had children younger than 5 years of age at the time the survey was conducted. The 
sample is considered both nationally and regionally representative of Malawians aged 15-49 
(MDHS, 2017). I analyzed data from the Individual Women’s Questionnaire, which includes 
information on women’s sociodemographic characteristics, reproductive behavior and intentions, 
contraceptive use, antenatal and postnatal care utilization, and children’s health. 
Study Sample 
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The 2015-16 Malawi Demographic and Health Survey (MDHS) sampled 26,261 
households, 24,562 female respondents, and 7,478 male respondents to identify population 
characteristics and health issues relevant to Malawian citizens and key stakeholders. Data from 
the Malawi Population and Housing Census (MPHC) were used to inform the sampling frame for 
the MDHS by providing a list of standard enumeration areas (SEA), which were used to identify 
households (NSO, 2017: 2).  
Sampling Methods 
Sampling was conducted in two stages. First, Malawi’s 28 administrative districts were 
stratified into urban or rural areas. Second, systematic selection was conducted to determine the 
number of households sampled per urban/rural cluster (NSO, 2017: 2). Oversampling was used 
to account for small regional populations and uneven population distribution. Weights were 
applied to adjust for the greater population density of Malawi’s Southern region (46% of the 
population) compared to the Northern region (12% of the population) (NSO, 2017: 31). All 
women aged 15-49 who were permanent residents of the selected household or had spent the 
night at the selected household were eligible for interview while one-third of men who met these 
same characteristics were eligible for interview (NSO 2017: 2).  
Data Collection Methods  
Data from the Malawi Demographic and Health Survey were collected between October 
2015 and February 2016 by the National Statistical Office (NSO) of Malawi. The response rate 
was 99% for household data, 98% for data collected from women, and 95% for data collected 
from men (NSO, 2017: 7). Thirty-seven field teams collected the data, which were stored 
securely and processed at the NSO in Zomba, Malawi. The 2015-16 MDHS consists of the 
Household Questionnaire, the Woman’s Questionnaire, the Man’s Questionnaire, and the 
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Biomarker Questionnaire, all of which are based on standard questionnaires developed by the 
DHS Program (NSO, 2017: 2). The questionnaires were produced in English, translated into 
Chichewa and Tumbuku, and administered via computer- assisted personal interviewing (CAPI), 
allowing respondents to choose the language in which the survey was conducted (NSO, 2017: 3). 
The Household Questionnaire collected basic demographic information about household 
members (age, sex, marital status, education, and relationship to the head of household) as well 
as information about the residence (amenities, building materials, and ownership of “various 
durable goods”) —a measure that was used to determine wealth (NSO, 2017: 11).  
The Woman’s Questionnaire collected information on women’s background 
characteristics (age, educational attainment, occupation, exposure to media), reproductive and 
maternal health (pregnancy outcomes, number of children, breastfeeding, antenatal care, 
postnatal care, delivery), family planning knowledge and behaviors (knowledge and use of 
contraception, sources of information on contraception), fertility preferences (ideal number of 
children, desire for more children), child health (immunization coverage, illnesses), marriage and 
sexual activity (marital status, recent sexual activity, use of condoms), knowledge of STDs and 
HIV, exposure to and attitudes towards domestic violence, and mortality. Data on knowledge and 
use of family planning methods were collected from all women by asking if they had ever heard 
of each of the 13 methods included in the questionnaire (female sterilization, male sterilization, 
injectables, intrauterine devices (IUDs), implants, contraceptive pills, male condoms, female 
condoms, emergency contraception, the standard days method, lactational amenorrhea method, 
the rhythm method, withdrawal) or a different method not mentioned in the questionnaire that 
men or women can use to avoid pregnancy (NSO, 2017: 563). Respondents who had knowledge 
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of the method were also asked if they had ever used the method. If respondents had knowledge 
of or had ever used a particular method, they were asked if they currently used the method.  
The questionnaire on child immunization records contains a checklist for the following 
vaccines: oral polio vaccine, DPT-HEPB-HIB, PCV/Pneumococcal, rotavirus, measles, and 
Vitamin A (NSO, 2017: 582). DHS interviewers first asked if respondents had a Health Passport 
where the child’s vaccinations were written. Using respondents’ health passport or other 
documents, interviewers recorded the date, if available, on which the respondents’ children 
received each required dose for each of the above vaccines. If the respondent did not have 
documentation of vaccinations, interviewers asked if the child had ever received one of the 
above vaccinations using a description of how the vaccines are administered to help respondents 
remember. For the pneumococcal vaccine, interviewers asked if the child had ever received “an 
injection in the thigh to prevent pneumonia” and, if yes, how many times (NSO, 2017: 584). For 
the rotavirus vaccine, interviewers asked if the child had ever received “liquid in the mouth to 
prevent diarrhea” (NSO, 2017: 584). Vaccination data were collected on living children ages 0-
35 months.  
STUDY VARIABLES 
Dependent Variable  
My primary variable of interest was whether women had vaccinated their children with the 
rotavirus and pneumococcal vaccines. Using data on the youngest child in each household, I 
defined routine vaccine adopters (“adopters”) as women whose youngest child received the full 
dose of both the monovalent human rotavirus (RV1, two doses) and the pneumococcal conjugate 
(PCV13, three doses) vaccines by age 3 (35 months). Women whose first child received partial 
doses of either vaccine, received the full dose of only one of the vaccines, or did not know 
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whether their child had received the vaccines were coded as 0 (“non-adopters”). Vaccination 
status was measured by confirming markings or dates on the child’s vaccination card or mother’s 
self-report. 
Independent Variables 
Independent variables were grouped into three domains: health service utilization, 
empowerment, and socio-demographic characteristics. Women’s health service utilization was 
measured through an index constructed from five binary variables: current modern contraceptive 
use, antenatal care visits, postnatal check, facility-based delivery, and healthcare access. Each of 
these binary indicators was constructed from existing variables. To identify modern 
contraceptive users, I first created a subsample of currently married/partnered women who were 
not currently pregnant, not sterilized or declared infecund, non-abstinent (i.e., had had sex in the 
last four weeks), not currently breastfeeding, had not given birth in the past year, and who either 
do not want any more children or want to wait at least two years before having more children. 
Within this sample, I identified modern contraceptive users as women who reported current use 
of either the pill, IUD, injections or implants/Norplant. Women who were not currently using 
contraceptives, were currently pregnant, or used a different type of contraceptive were classified 
as non-users.  
 Binary variables were also constructed to identify whether respondents had received three 
or more antenatal care visits, whether respondents had a postnatal care check for their youngest 
child at 12 months, and whether they delivered their youngest child at a health facility (vs. at 
home/other). Finally, women’s ability to access health services was constructed as a binary 
variable based on whether any of the following were considered a “big problem” (vs. not a big 
problem) for the respondent in case she became ill: getting permission to go to a health facility, 
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getting money needed for treatment, perceived distance to the health facility, and not wanting to 
go alone. Respondents were coded as 0 if any of the above presented a problem accessing 
medical advice or treatment; otherwise, they were coded as 1. Using these five binary variables, I 
then constructed an index of health service utilization, with 1 point allocated for each service 
utilized and 1 point allocated if accessing health care was not perceived as a big problem. This 
index was recoded into three categories: low service utilization (< 2 points), medium service 
utilization (2-3 points), and high service utilization (4-5 points).  
Two variables were included to examine women’s empowerment: decision-making 
power and attitudes towards violence. Decision-making power was assessed through an index of 
women’s ability to make decisions about their own healthcare, large household purchases, and 
visits to friends or relatives. This index, which did not include respondent’s participation in 
decisions about what to do with her husband/partner’s earnings, has been validated in other 
assessments of empowerment using DHS data (Asaolu et al., 2018). The index assigned a value 
of 1 for each of these decisions that women reported making alone or jointly with their 
partner/husband. Women whose husband/partner or someone else made the decision were coded 
as 0. The index summed these scores for a household decision-making index that ranged from 0-
3. To evaluate women’s attitudes towards violence, I constructed a binary variable based on 
whether respondents believed a husband was justified in beating his wife in any one of five 
circumstances: if she goes out without telling him, if she neglects the children, if she argues with 
him, if she refuses to have sex with him, and if she burns the food. Respondents were coded as 0 
if they believed that violence was justified in any one of the above circumstances and as 1 if they 
believed that violence against women was never justified. 
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Women’s socio-demographic characteristics included education (none, primary level, 
secondary or higher), wealth quintile (based on a validated household asset index), current 
employment status (yes/no), and husband’s education (none, primary level, secondary or higher). 
To test whether women’s access to information was positively associated with their most recent 
child’s RV1 and PCV13 vaccination status, I included an index of exposure to media based on 
how often respondents read a newspaper or magazine, how often they listened to the radio, and 
how often they watched television. Respondents who had no exposure to any of the above media 
sources were coded as 0 while respondents who were exposed to any of the above media sources 
less than once per week were coded as 1, and respondents who were exposed to any of the above 
media at least once per week were coded as 2.  
 Covariates 
Based on previous studies examining vaccine uptake and studies on women’s 
empowerment, covariates for maternal background characteristics, child’s background 
characteristics, and community characteristics were included. Child characteristics included 
child’s gender and age (12-36 months). Maternal characteristics included mother’s age. 
Community characteristics included the region of residence (Northern, Central or Southern 
region), and urban/rural status.  
ANALYTICAL PLAN 
The analysis plan described below describes the procedures used to assess the 
relationship between the independent variables and the dependent variable: complete coverage of 
RV1/PCV13. All analyses were conducted with statistical analysis software (Stata) for Mac, 
version 15 (StataCorp, 2017). Descriptive statistical analyses and bivariate analyses were 
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conducted using a sample weight that was generated for the dataset to account for differences in 
sampling probabilities. 
Descriptive Statistics  
Descriptive statistics and frequencies of the study variables were generated to assess the 
proportion of missing cases and characteristics of the sample population (Table 1). Variables 
indicating mother’s education and husband’s education were recoded into 3-category variables. 
Responses of “don’t know” were recoded as missing for youngest child’s uptake of the rotavirus 
and pneumococcal vaccines, number of ANC visits, PNC check, attitudes towards violence, and 
husband or partner’s education. For variables used to construct the household decision-making 
index, women who responded that someone other than her husband, herself, or someone else 
made the decision—fewer than 0.75% of respondents—were reclassified as missing.  
Bivariate Analysis  
Cross-tabulations were used to explore the relationship between the independent 
variables and the dependent outcome variable (full uptake of the RV1 and PCV13 vaccines). The 
Pearson’s chi-square and t-test statistics and respective p-values were used to determine 
statistical significance. 
Logistic Regression   
Multivariate logistic regression was used to examine which characteristics were 
associated with uptake of the RV1 and PCV13 vaccines. This approach was selected because the 
dependent variable is binary. Models were constructed to include 1) a main effects model with 
no covariates, 2) a main effects model with covariates, 3) an interaction model that tested for an 
interaction effect between household-decision-making and maternal education, and 4) an 
interaction model that tested for an interaction effect between household-decision-making and 
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maternal wealth. The best-fitting model was selected using R-squared, AIC and BIC scores as 
well as the statistical significance of the interaction term (Appendix: Table A). Crude and 
adjusted odds ratios and their 95% confidence intervals (95% CI) were estimated. Statistical 
significance was set at a p-value of less than 0.05.  
RESULTS 
Sample Characteristics 
The final, weighted analytic sample included 951 women. Characteristics of this sample 
are presented in Table 2. The mean age of respondents was 28.7 years old (SD=9.25). 
Respondents had high levels of health service utilization, with 46% having a score of 4-5 (high) 
and 53% having a score of 2-3 (medium). Nearly 44% of respondents were able to participate in 
all three types of family decisions measured while only 15% participated in no family decisions. 
The majority of respondents believed that violence towards women was not justified in any 
circumstance (84.9%). Most respondents lived in rural areas (79%), with 45% residing in the 
Southern region, 43% from the Central region, and 11.9% from the Northern region. More than 
two-thirds of women were currently employed (69%) and the majority had received a primary 
school level of education (63.9%) while 7.6% of respondents had no education. 39% of 
respondents were not exposed to any media sources (newspaper/magazine, radio, television) 
while 42% were exposed to any one of these sources at least once per week. A comparison of 
health service utilization, decision-making, attitudes towards violence, and media exposure 
between respondents in the final analytic sample and MDHS respondents who were not included 
in the final analytic sample is presented in Figure 1. 
Table 2. Characteristics of study participants (n = 951) 
 n % 
Outcome variable   
Adopters (complete RV1 and PCV13) 760 79.92 
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Health service utilization   
Low (0 -1) 12 1.21 
Medium (2-3) 501 52.67 
High (4-5) 439 46.12 
   
Empowerment   
Decision-making power   
0 146 15.38 
1 168 17.70 
2 220 23.12 
3 417 43.81 
   
Attitudes toward violence (never justified) 808 84.90 
   
Socio-demographic characteristics   
Maternal education    
None 72 7.57 
Primary 607 63.90 
Secondary and above 272 28.60 
   
Wealth index   
Poorest 153 16.11 
Poorer 225 23.67 
Middle 165 17.39 
Richer 182 19.12 
Richest 226 23.72 
   
Currently employed 654 68.69 
   
Husband's education    
No education 54 5.70 
Primary 510 53.65 
Secondary and above 387 40.65 
   
Media Exposure   
0 372 39.13 
1 178 18.70 
2 401 42.17 
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Child characteristics   
Female 477 50.15 
   
Age   
13-24 months 197 20.74 
25-36 months 754 79.26 
   
Maternal age (years)   
15-19 27 2.87 
20-24 255 26.80 
25-29 254 26.65 
30-34 221 23.26 
35-49 194 20.39 
Mean (years) 28.7  
   
Community characteristics   
Geographical region   
Northern 113 11.88 
Central 412 43.32 
Southern 426 44.80 
   
Rural 753 79.12 
   
Total (n) 951 100% 
Source: MDHS, 2015-16   
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Bivariate Analysis 
Bivariate analysis of RV1/PCV13 adopters’ and non-adopters’ background characteristics 
is presented in Table 3. Among respondents in the lowest age category, approximately half were 
adopters and half were non-adopters. For all other age categories, adopters comprised the 
majority. Adopters were on average slightly older than non-adopters (28.9 vs. 27.8 years old); 
however, this difference was not statistically significant. No significant differences were 
observed between adopters and non-adopters with respect to their youngest child’s gender, 
child’s mean age, and place of residence.  
Table 3. Bivariate associations between RV1/PCV13 adoption and respondents’ 
background characteristics (n = 951) 
 Non-adopters Adopters p-value 
Child characteristics    
Female 90 (18.9%) 387 (81.09%) 0.462 
0
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2
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3
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Fig. 1 Mean health service utilization, decision-making, violence, and media 
scores for study participants vs. non-participants
Study	Participants	(n	=	951) Non-participants	(n	=	23,610)
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Age    
13-24 months 36 (18.11%) 162 (81.89%)  
25-36 months 155 (20.59%) 599 (79.41%)  
Mean (months) 27.7 27.9 0.693 
    
Maternal age (years)    
15-19 13 (48.81%) 14 (51.19%)  
20-24 56 (22.11%) 199 (77.9%)  
25-29 49 (19.17%) 205 (80.83%)  
30-34 41 (18.75%) 180 (81.25%)  
35-49 31 (16.05%) 163 (83.95%)  
Mean (years) 27.8 28.9 0.078 
    
Community characteristics    
Geographical region    
Northern 18 (15.49%) 96 (84.51%)  
Central 73 (17.66%) 339 (82.34%)  
Southern 101 (23.63%) 326 (76.37%)  
    
Rural 147 (19.46%) 761 (79.92%) 0.526 
    
Total (n) 191 760   
Source: MDHS, 2015-16    
 
Bivariate analysis of adoption of RV1/PCV13 and key independent variables is presented 
in Table 4. Adopters had a higher mean score of health service utilization (2.47) compared to 
non-adopters (2.37), although this difference was not statistically significant (p = 0.095). 
Adopters also had higher mean decision-making scores (2.01 vs. 1.74) and higher mean media 
exposure compared to non-adopters (1.09 vs. 0.78), and these differences were statistically 
significant. Among respondents who believed that violence was never justified, 81.6% were 
adopters and 18.3% were non-adopters (p = 0.015).  
Adopters and non-adopters also differed on socio-economic characteristics. Adopters had 
on average 6.7 years of education while non-adopters had 5.6 (p = 0.002). Among respondents 
 36 
who were currently employed, 83.6% were adopters and 16.4% were non-adopters (p = 0.003). 
Adopters’ husbands/partners had slightly higher mean education levels compared to non-
adopters (7.86 vs. 7.18); however, this difference was not statistically significant (p = 0.063). 
 
Table 4. Bivariate associations between RV1/PCV13 adoption and independent variables (n 
= 951) 
 Non-adopters Adopters p-value 
Health service utilization    
Low (0 -1) 2 (15.88%) 10 (84.12%)  
Medium (2-3) 115 (22.21%) 386 (77.01%)  
High (4-5) 74 (16.86%) 365 (83.14%)  
Mean 2.37 2.47 0.095 
    
Empowerment    
Decision-making power    
0 38 (26.24%) 108 (73.76%)  
1 40 (23.7%) 128 (76.3%)  
2 46 (21.06%) 174 (78.94%)  
3 66 (15.93%) 350 (84.07%)  
Mean 1.74 2.01 0.011 
    
Attitudes toward violence (never justified) 148 (18.34%) 660 (81.66%) 0.015 
    
Socio-demographic characteristics    
Maternal education     
None 22 (30.11%) 50 (69.89%)  
Primary 132 (21.76%) 475 (78.24%)  
Secondary and above 37 (13.66%) 235 (86.34%)  
Mean (years) 5.6 6.7 0.002 
    
Wealth index    
Poorest 41 (26.81%) 112 (73.19%)  
Poorer 46 (20.55%) 179 (79.45%)  
Middle 32 (19.16%) 134 (80.84%)  
Richer 38 (20.70%) 144 (79.30%)  
Richest 34 (15.20%) 191 (84.80%)  
    
Currently employed 107 (16.37%) 547 (83.63%) 0.003 
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Husband's education     
No education 19 (34.39%) 36 (65.61%)  
Primary 104 (20.43%) 406 (79.57%)  
Secondary and above 68 (17.61%) 319 (82.39%)  
Mean (years) 7.18 7.86 0.063 
    
Media Exposure    
0 102 (27.37%) 270 (72.63%)  
1 29 (16.51%) 149 (83.5%)  
2 60 (14.89%) 342 (85.11%)  
Mean 0.78 1.09 <0.001 
    
Total (n) 191 760   
Source: MDHS, 2015-16    
 
 
Logistic Regression 
Logistic regression analysis of factors associated with being a routine vaccine adopter 
(having complete coverage of both the RV1 and PCV13 vaccines for one’s youngest child) are 
presented in Table 5. Although the odds of being an adopter increased with health service 
utilization scores, health service utilization was not significantly associated with vaccine 
adoption in either the unadjusted or adjusted regression analyses. However, as hypothesized, 
women’s decision-making power was positively associated with RV1/PCV13 adoption. 
Compared to women who participated in zero family decision, women who participated in all 
three types of family decisions were 65% more likely to be routine vaccine adopters (p < 0.05). 
In the unadjusted model, the odds of RV1/PCV13 adoption increased incrementally with 
decision-making power, but this trend did not hold for the adjusted model.  
Women who believed that violence against women was never justified had significantly 
higher odds of being vaccine adopters in both the adjusted and unadjusted models. Compared to 
women who believed that violence was justified in any one of five circumstances, women who 
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believed that violence against women was not justified were 55% more likely to be vaccine 
adopters (p <0.05). 
With respect to women’s socio-demographic characteristics, only employment and media 
exposure were significantly associated with being a vaccine adopter in the unadjusted regression 
analysis. Compared to women who were not currently employed, employed women were 44% 
more likely to be an adopter (p < 0.05). Compared to women with no media exposure, women 
who were exposed to newspaper or magazine, radio, or television at least once per week were 
57% more likely to be adopters of the RV1/PCV13 vaccines (p <0.05). In the unadjusted 
regression, the odds of being an adopter increased significantly with increasing exposure to 
media. In the unadjusted analysis, women with a secondary level of education or higher and 
women belonging to the highest wealth quintile were more than twice as likely as their 
counterparts to be vaccine adopters (p <0.01); however, these effects diminished in the adjusted 
model. A similar pattern was observed with respect to women’s husband’s/partner’s educational 
level. Women whose husbands/partners had a primary education were 89% more likely to be 
adopters than women whose husbands/partners had no education (p < 0.05) while women whose 
husbands/partners had a secondary education or higher were 2.4 times more likely to be adopters 
(p <0.01). Husband’s/partner’s education was not statistically significant in the adjusted model.  
 
Table 5. Logistic regression of factors associated with routine vaccine adopters  
 CrOR (95%CI) P-value aOR (95%CI) P-value 
Health service utilization (Ref: low) 1.00  1.00  
Medium (2-3) 0.71 0.668 0.51 0.424 
High (4-5) 1.10 0.901 0.73 0.705 
     
Empowerment     
Decision-making power (Ref: 0) 1.00  1.00  
1 1.32 0.294 1.39 0.233 
2 1.79 0.024 1.74 0.041 
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3 1.94 0.003 1.65 0.035 
     
Violence (Ref: justified) 1.00  1.00  
Never justified 1.65 0.013 1.55 0.040 
     
Socio-demographic characteristics     
Maternal education (Ref: none) 1.00  1.00  
Primary 1.53 0.123 1.28 0.420 
Secondary and above 2.47 0.004 1.57 0.222 
     
Wealth index (Ref: poorest) 1.00  1.00  
Poorer 1.16 0.558 1.13 0.650 
Middle 1.39 0.220 1.19 0.547 
Richer 1.36 0.250 0.96 0.889 
Richest 2.21 0.004 1.32 0.440 
     
Currently employed (Ref: no) 1.00  1.00  
Yes 1.61 0.004 1.44 0.040 
     
Husband's education (Ref: none) 1.00  1.00  
Primary 1.89 0.034 1.86 0.056 
Secondary and above 2.38 0.005 1.76 0.113 
     
Media Exposure (Ref: 0) 1.00  1.00  
1 1.82 0.010 1.54 0.080 
2 2.03 0.000 1.57 0.025 
Source: MDHS, 2015-16     
 
 
Interaction effects between women’s decision-making power and education and between 
women’s decision-making power and wealth were also tested but did not improve model fit 
(Appendix, Table 1). In a model that tested each of the health service utilization index variables 
separately, only antenatal care visits were significantly associated with being a vaccine adopter, 
with women who had three or more ANC visits 80% more likely to be an adopter than women 
with fewer than three visits (p <0.05) (Appendix, Table 2). 
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DISCUSSION 
This study suggests that factors associated with Malawian women’s empowerment, including 
their ability to participate in family decisions and their attitudes towards violence against women, 
are positively associated with adoption of a recently-introduced health technology: the RV1 and 
PCV13 vaccines. Women’s access to information, as measured through media exposure, and 
women’s participation in socio-economic life, as measured through current employment status, 
were also positively associated with adoption of new childhood vaccines even after including a 
number of important covariates, such as child’s age, women’s age, and region of residence. 
These findings are consistent with characteristics associated with “early adopters” of health 
innovations as proposed through diffusion of innovation theory. 
 In contradiction to diffusion of innovation theory, women’s prior experience with and 
ability to access existing health technologies (assessed through an index of health service 
utilization) were not significantly associated with adoption of the RV1 and PCV13 vaccines. One 
possible explanation for this finding involves significant differences between attitudes and 
uptake behaviors surrounding childhood vaccines (particularly the RV1 and PCV13 vaccines) 
and attitudes and uptake behaviors associated with the services included in the utilization index. 
For example, although modern contraceptives may be considered an innovative health 
technology, women’s use of modern contraceptives is perhaps a better indication of their beliefs 
about, and ability to control, their own reproductive and sexual health rather than their beliefs 
and ability to make decisions about their children’s health. In addition, this study analyzed 
vaccination outcomes for children ages 12-35 months. However, women’s utilization of 
postnatal care checks within the child’s first two months of life and women’s decision to deliver 
at a facility reflect service uptake behaviors associated with infant health rather than children 
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who are at least one year of age. It is unclear why other factors associated with characteristics of 
early adopters, including educational attainment and wealth, were not significant predictors of 
RV1/PCV13 adoption.  
The results of this study also suggest the need for further research on the relationship 
between women’s decision-making power within the family and vaccine uptake behavior for 
their children. Women’s ability to make decisions about their children’s health is often used as 
an indication of her empowerment or autonomy, which is in turn associated with utilization of 
maternal and child health services (Palamuleni & Adebowale, 2014; Ghose et al., 2017; Chol et 
al., 2019). My findings provide further evidence for this association, as women who participated 
in multiple household decisions had greater odds of adopting recently-introduced childhood 
vaccines. However, it is unclear why women who participated in two household decisions were 
74% more likely to adopt the RV1 and PCV13 vaccines than women who participated in no 
decisions, while women who participated in all three household decisions were only 65% more 
likely to adopt the RV1 and PCV13 vaccines. It is possible that women’s participation in 
decisions about their children’s health is more widely accepted than women’s participation in 
other types of family decisions, particularly economic expenditures. Further research is needed to 
understand how women’s participation in different types of household decisions impact their 
willingness and ability to adopt health innovations for their children. 
Strengths and Limitations 
The major strength of this study is use of a large, nationally representative dataset with 
validated measures. Use of this dataset makes the findings of this study generalizable to other 
currently married/partnered Malawian mothers ages 15-49. In addition, this study represents a 
novel approach towards analyzing vaccine uptake behavior. To my knowledge, this is the first 
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study that has attempted to predict HPV vaccine uptake behavior among Malawian families 
using publicly available DHS data. 
This study is limited primarily by the use of RV1 and PCV13 vaccines as a proxy for the 
HPV vaccine. While RV1 and PCV13 offer the closest approximation to the HPV vaccine based 
on its relatively recent introduction to Malawian society, important distinctions between 
RV1/PCV13 and the HPV vaccine may limit the accuracy of this study’s predictions. The HPV 
vaccine targets pre-adolescent Malawian girls and aims to protect against a sexually transmitted 
infection. Its association with sexual behavior among a unique target population may raise 
concerns among parents and community members about the vaccine’s effects on girls’ sexual 
and reproductive health (PATH, 2009; Ezeanochie & Olagbuki, 2014)—concerns that are not 
associated with the RV1 and PCV13 vaccines. This study is also limited by its exclusive focus 
on mothers as decision-makers for vaccine uptake. Studies in Uganda have found that adolescent 
girls’ themselves may play a key role in deciding whether to receive the HPV vaccine (PATH, 
2009). The role of Malawian girls in HPV vaccine uptake has received insufficient attention 
within the literature. Additional limitations surrounding assessment of RV1/PCV13 uptake 
include possible reporting bias on vaccine data (Bar-Zeev et al., 2015).  
CONCLUSION 
Reducing rates of cervical cancer in Malawi remains a challenge. The findings of this 
study can be used to improve HPV vaccine coverage across Malawi by targeting families in 
which women have lower levels of empowerment, less exposure to media, and lower rates of 
employment. My research also suggests that different strategies may be needed to increase HPV 
vaccine uptake in different populations. For example, although the diffusion of innovation theory 
suggests that women who have higher levels of education and higher wealth status are more 
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likely to adopt a health innovation, my findings suggest that differences in empowerment, 
employment, and media exposure may have greater bearing on vaccination uptake behaviors 
than wealth and education alone. By identifying characteristics of families who are less likely to 
vaccinate their daughters with the HPV vaccine, my research can inform HPV vaccine 
implementation and information campaigns to increase coverage rates—a critical step towards 
reducing cervical cancer mortality in Malawi. 
 Further research is needed to assess whether these same associations emerge when 
measuring actual HPV vaccine uptake in Malawi. Although the RV1 and PCV13 vaccines were 
selected as the closest approximation of the HPV vaccine within the MDHS dataset, differences 
between these vaccines highlight the need for further research on determinants of HPV vaccine 
uptake among Malawian families. Qualitative research may provide a more nuanced examination 
of processes of innovation decision-making and adoption behaviors and how these processes 
intersect with uptake of newly introduced vaccines for their children. Additional quantitative 
research may provide insight into other individual or community-level characteristics that 
determine uptake of new vaccines. 
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APPENDIX 
 
Appendix Table 1. Model selection for logistic regression analysis 
  Model 1 Model 2 Model 3 Model 4 
 
Health service utilization (Ref: low) 1.000 1.000 1.000 1.000 
 (0.000) (0.000) (0.000) (0.000) 
Health service utilization - med 0.572 0.514 0.547 0.516 
 (0.464) (0.428) (0.450) (0.430) 
Health service utilization - high 0.777 0.729 0.781 0.768 
 (0.635) (0.609) (0.647) (0.644) 
Decision-making (Ref: 0) 1.000 1.000 1.000 1.000 
 (0.000) (0.000) (0.000) (0.000) 
Decision-making: 1  1.340 1.393 1.113 1.285 
 (0.366) (0.387) (0.972) (1.453) 
Decision-making: 2 1.666 1.741+ 1.997 4.923 
 (0.445) (0.472) (1.824) (5.635) 
Decision-making: 3 1.640+ 1.653+ 3.772 9.155+ 
 (0.384) (0.394) (3.152) (9.666) 
Attitudes towards violence  1.496 1.548+ 1.585+ 1.650+ 
 (0.310) (0.329) (0.340) (0.361) 
Mother's Education (Ref: None) 1.000 1.000 1.000 1.000 
 (0.000) (0.000) (0.000) (0.000) 
Mother's education - primary 1.271 1.275 1.659 1.743 
 (0.374) (0.385) (1.197) (1.318) 
Mother's education -secondary/higher 1.548 1.574 2.789 2.253 
 (0.561) (0.585) (2.353) (2.005) 
Wealth quintile (Ref: poorest) 1.000 1.000 1.000 1.000 
 (0.000) (0.000) (0.000) (0.000) 
Wealth quintile - poorer 1.106 1.128 1.144 1.668 
 (0.290) (0.300) (0.307) (1.094) 
Wealth quintile - middle 1.267 1.188 1.188 2.288 
 (0.354) (0.339) (0.343) (1.565) 
Wealth quintile - richer 1.053 0.960 0.954 3.404 
 (0.296) (0.280) (0.280) (2.615) 
Wealth quintile - richest 1.320 1.319 1.366 5.093 
 (0.429) (0.474) (0.494) (4.443) 
Employed 1.453+ 1.442+ 1.443+ 1.455+ 
 (0.251) (0.256) (0.258) (0.263) 
Husband's education (Ref: none) 1.000 1.000 1.000 1.000 
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 (0.000) (0.000) (0.000) (0.000) 
Husband's education - primary 1.763 1.861 1.847 1.686 
 (0.562) (0.605) (0.610) (0.570) 
Husband's education - secondary/higher 1.663 1.764 1.733 1.525 
 (0.582) (0.632) (0.629) (0.565) 
Media exposure (Ref: 0) 1.000 1.000 1.000 1.000 
 (0.000) (0.000) (0.000) (0.000) 
Media exposure - 1 1.521 1.542 1.539 1.504 
 (0.372) (0.382) (0.383) (0.379) 
Media exposure - 2 1.607+ 1.572+ 1.551+ 1.594+ 
 (0.320) (0.317) (0.316) (0.330) 
Mother's age (Ref: 15-19)  1.000 1.000 1.000 
  (0.000) (0.000) (0.000) 
Mother's age -  20-24  2.168 2.245 2.433+ 
  (0.925) (0.957) (1.053) 
Mother's age - 25-29  2.479+ 2.604+ 2.759+ 
  (1.064) (1.121) (1.204) 
Mother's age  - 30-34  3.043+ 3.222* 3.465* 
  (1.341) (1.425) (1.549) 
Mother's age - 35-49  2.763+ 2.911+ 3.251* 
  (1.232) (1.300) (1.471) 
Child Gender (Ref: Male)  1.352 1.371 1.386 
  (0.228) (0.233) (0.239) 
Child Age (Ref: 13-24 months)  1.000 1.000 1.000 
  (0.000) (0.000) (0.000) 
Child Age - 25-36 months  0.847 0.847 0.864 
  (0.171) (0.171) (0.178) 
Region (Ref: Northern)  1.000 1.000 1.000 
  (0.000) (0.000) (0.000) 
Region - Central  0.783 0.766 0.716 
  (0.205) (0.202) (0.192) 
Region - South  0.648 0.649 0.623 
  (0.160) (0.162) (0.157) 
Rural  1.192 1.177 1.192 
  (0.301) (0.299) (0.307) 
Decision-making(1) x No education   1.000 1.000 
   (0.000) (0.000) 
Decision-making(1) x Primary  education   1.449 1.428 
   (1.353) (1.388) 
Decision-making(1) x Secondary education   0.906 1.098 
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   (0.998) (1.299) 
Decision-making(2) x No education   1.000 1.000 
   (0.000) (0.000) 
Decision-making(2) x Primary education   0.945 1.035 
   (0.912) (1.032) 
Decision-making(2) x Secondary education   0.613 1.162 
   (0.676) (1.360) 
Decision-making(3) x No education   1.000 1.000 
   (0.000) (0.000) 
Decision-making(3) x Primary education   0.430 0.415 
   (0.378) (0.376) 
Decision-making(3) x Secondary education   0.317 0.394 
   (0.317) (0.416) 
Decision-making(1) x Poorest    1.000 
    (0.000) 
Decision-making(1) x Poorer    1.408 
    (1.247) 
Decision-making(1) x Middle    0.895 
    (0.851) 
Decision-making(1) x Richer    0.502 
    (0.501) 
Decision-making(1) x Richest    0.451 
    (0.535) 
Decision-making(2) x Poorest    1.000 
    (0.000) 
Decision-making(2) x Poorer    0.752 
    (0.684) 
Decision-making(2) x Middle    0.295 
    (0.274) 
Decision-making(2) x Richer    0.144+ 
    (0.139) 
Decision-making(2) x Richest    0.108+ 
    (0.114) 
Decision-making(3) x Poorest    1.000 
    (0.000) 
Decision-making(3) x Poorer    0.464 
    (0.366) 
Decision-making(3) x Middle    0.421 
    (0.345) 
Decision-making(3) x Richer    0.198 
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    (0.176) 
Decision-making(3) x Richest    0.229 
    (0.223) 
Constant 0.715 0.248 0.162 0.085 
 (0.656) (0.275) (0.212) (0.123) 
     
Observations 961 961 961 961 
AIC 956.7 960.1 968.8 981.8 
BIC 1044.3 1091.6 1129.4 1200.9 
-2 Log Likelihood -460.4 -453.1 -451.4 -445.9 
df 17 26 32 44 
Pseudo R-Squared 0.0476 0.0627 0.0662 0.0775 
Standard errors in parentheses     
** p<0.001, * p<0.01, + p<0.05     
Source: MDHS, 2015-16     
 
 
Appendix Table 2. Logistic regression analysis of RV1/PCV13 adoption with 
independent health service utilization indicators 
 aOR  
 
Modern contraceptive use (Ref: non-user) 1.427 
 (0.329) 
Antenatal care (Ref: < 3 visits) 1.808+ 
 (0.459) 
Postnatal care check within 2 months (Ref: No) 1.091 
 (0.192) 
Facility delivery (Ref: Home/other) 0.774 
 (0.258) 
Medical Care Access (Ref: Big problem) 1.252 
 (0.243) 
Decision-making (Ref: 0) 1.000 
 (0.000) 
Decision-making: 1  1.329 
 (0.371) 
Decision-making: 2 1.650 
 (0.450) 
Decision-making: 3 1.594 
 (0.382) 
Attitudes towards violence  1.553+ 
 (0.332) 
 48 
Mother's Education (Ref: None) 1.000 
 (0.000) 
Mother's education - primary 1.234 
 (0.376) 
Mother's education -secondary/higher 1.512 
 (0.567) 
Wealth quintile (Ref: poorest) 1.000 
 (0.000) 
Wealth quintile - poorer 1.135 
 (0.305) 
Wealth quintile - middle 1.196 
 (0.343) 
Wealth quintile - richer 0.969 
 (0.286) 
Wealth quintile - richest 1.319 
 (0.477) 
Employed 1.407 
 (0.251) 
Husband's education (Ref: none) 1.000 
 (0.000) 
Husband's education - primary 1.793 
 (0.586) 
Husband's education - secondary/higher 1.665 
 (0.600) 
Media exposure (Ref: 0) 1.000 
 (0.000) 
Media exposure - 1 1.559 
 (0.388) 
Media exposure - 2 1.580+ 
 (0.321) 
Mother's age (Ref: 15-19) 1.000 
 (0.000) 
Mother's age -  20-24 2.233 
 (0.960) 
Mother's age - 25-29 2.521+ 
 (1.090) 
Mother's age  - 30-34 3.117+ 
 (1.384) 
Mother's age - 35-49 2.797+ 
 (1.262) 
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Child Gender (Ref: Male) 1.315 
 (0.222) 
Child Age (Ref: 13-24 months) 1.000 
 (0.000) 
Child Age - 25-36 months 0.821 
 (0.168) 
Region (Ref: Northern) 1.000 
 (0.000) 
Region - Central 0.742 
 (0.200) 
Region - South 0.644 
 (0.163) 
Rural 1.134 
 (0.289) 
Constant 0.094* 
 (0.084) 
  
Observations 961 
AIC 961.2 
BIC 1107.2 
-2 Log Likelihood -450.6 
df 29 
Pseudo R-Squared 0.0678 
Standard errors in parentheses  
** p<0.001, * p<0.01, + p<0.05  
Source: MDHS, 2015-16  
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